Pay in 4 interest-free payments of $5.88 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Brown and Lawrence S
This article is not for them
released preliminary topline week 96 results from Phase 2b study HARMONY The study previously met its primary endpoint of 1 stage improvement in fibrosis with no worsening of MASH after 24 weeks of treatment for both the 50mg EFX (41%) and 28mg EFX (39%) dose groups, compared to 20% for the placebo arm
Alternative treatments should be discussed with a healthcare provider to ensure proper blood sugar control or weight loss while minimizing digestive discomfort. Disclaimer: This information is intended for general knowledge and informational purposes only and does not constitute medical advice
US$ 27.33
US$ 21.55
US$ 22.03
US$ 29.60
